Portfoliotracker

CorMedix Inc.

CRMD · NASDAQGM · Healthcare Biotechnology 79/100 B

4,820 $
▲ +0,160 (+3,43 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 13:42
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score79 / 100 Market cap378 mil. $ P/E8,0 Forward P/E14,1 P/S0,9 P/B0,8 EV/EBITDA– Dividend yield– FCF yield81,41 % EPS1,97 $ Net margin15,5 % Return on equity15,3 % Beta1,48 Debt / equity0,32
52-week range 4,65 to 13,02
3-month average volume1,4 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Employees
191
Country
United States
Fiscal year end
31. 12.
Data since
13. 5. 2010

Explore further

Similar companies VTVTCAPR

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account